ANDREW RISING: Open Payments
NPI 1578194544 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,566 in 170 payments from 23 companies in 2025. Trend: 2023 $2,786 · 2024 $3,373 · 2025 $3,566
Food & beverage: $3,476Education: $90
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 25 | $629 |
| Amgen Inc. | 33 | $565 |
| ABBVIE INC. | 24 | $530 |
| Novartis Pharmaceuticals Corporation | 16 | $309 |
| Mallinckrodt Hospital Products Inc. | 11 | $279 |
| AstraZeneca Pharmaceuticals LP | 14 | $274 |
| GENZYME CORPORATION | 10 | $231 |
| Janssen Biotech, Inc. | 6 | $119 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| E.R. Squibb & Sons, L.L.C. | 4 | $81 |
Products named: Bimzelx, COSENTYX, ACTHAR, SAPHNELO, RINVOQ, KEVZARA, ENBREL, EVENITY.
Industry payments across FL — which companies pay providers there.
